Miguel López de Rodas

Also affiliated with Yale University, Clinica Universidad de Navarra

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity”.

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0543

N/A

0DataRank · unranked

40 citations

Alireza Khodadadi‐Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis Chiriboga +28 more

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004440

N/A

0DataRank · unranked

125 citations

Venkata Nagineni, Arvind Ravi, Ila Datar, Mari Mino–Kenudson, Germán Corredor +11 more

Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2457

N/A

0DataRank · unranked

14 citations

Yvonne Wang, Gang Peng, Jianlei Gu, Mari Mino–Kenudson, Jonathan W. Riess +6 more

Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100706

N/A

0DataRank · unranked

2 citations

Matthew S. Lara, Miguel López de Rodas, Guillaume Luxardi, Samantha Herbert, Michiko Shimoda +9 more

Distinct genomic and immunologic tumor evolution in germline TP53- driven breast cancers

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.03.588009

N/A

0DataRank · unranked

4 citations

David Hoyos, Renyta Moses, Ryan Hausler, Heena Desai, Anh N. Le +17 more

IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer

Molecular Cancer(2025)10.1186/s12943-025-02276-z

N/A

0DataRank · unranked

12 citations

Barani Kumar Rajendran, Imad ud Deen, Adrien Costantini, Miguel López de Rodas, Shruti Desai +5 more